Rekvina Laboratories Board Meeting November 13

The Board Meeting is scheduled to be held on 13th November, 2026. The primary agenda includes:

• Consideration and approval of Un-Audited Financial Results under Indian Accounting Standards (Ind AS) for the Quarter and Half Year ended on 30th September, 2026
• Any other agendas as may be considered necessary with the permission of the chair

In accordance with the Company's Code of Conduct for Prevention of Insider Trading, the trading window for the company's equity shares has been closed for all 'designated persons' from 1st October, 2026. The trading window will remain closed until the expiry of 48 hours after the financial results are made public.

Company CIN: L24231GJ1988PLC01145